Pharma BD Deal Intelligence
Merck & Co. Inc. / Cubist Pharmaceuticals
2014 · Acquisition/Merger · $9.5B · Complete
Announcement Sentiment
63
Positive
Outcome Score
41
Underwhelmed — fell short of the thesis.
Merck acquired Cubist Pharmaceuticals for $9.5B, an antibiotic-focused pharmaceutical firm.
Key facts
- Announced Dec 08, 2014
- Closed Jan 21, 2015
- Deal value $9.5B
- Deal type Acquisition/Merger
- Therapeutic area Infectious Disease
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals